ArticleCureus2026
Serial Serum Creatine Phosphokinase and Lactate Dehydrogenase Levels as Biomarkers of Severity and Intermediate Syndrome in Organophosphorus Compound Poisoning: A Prospective Observational Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Organophosphorus compound poisoning remains an important cause of morbidity and mortality in agrarian regions. Early identification of patients at risk of worsening toxicity and intermediate syndrome remains challenging. Serum creatine phosphokinase and lactate dehydrogenase may reflect neuromuscular and tissue injury and may therefore assist clinical risk stratification. Methods This prospective observational study included 80 adult patients with mild-to-moderate organophosphorus compound poisoning admitted to a tertiary care teaching hospital between March 2025 and June 2025. Poisoning severity was assessed using a modified Peradeniya Organophosphorus Poisoning (POP)-based clinical score. Serum creatine phosphokinase and lactate dehydrogenase levels were measured at admission, 48 hours, and 96 hours. Associations with poisoning severity and intermediate syndrome were evaluated using the Mann-Whitney U test, correlations with the severity score using Pearson correlation, and discriminative performance using receiver operating characteristic curve analysis. Results The mean age was 26.69 ± 8.70 years, 43 patients (53.8%) were male, and accidental exposure was the predominant mode of poisoning, observed in 60 patients (75.0%). Intermediate syndrome developed in eight patients (10.0%), and three patients (3.8%) died. Serum creatine phosphokinase and lactate dehydrogenase levels were significantly higher in moderate poisoning than in mild poisoning at admission, 48 hours, and 96 hours (all p < 0.001). Patients who developed intermediate syndrome had higher biomarker levels throughout hospitalization, including creatine phosphokinase at admission (1281.88 ± 631.83 vs. 434.32 ± 304.95 IU/L; p = 0.001) and lactate dehydrogenase at 48 hours (1516.88 ± 777.95 vs. 528.47 ± 303.78 IU/L; p = 0.001). Biomarker levels correlated positively with the severity score, with the strongest correlations observed for lactate dehydrogenase at admission (r = 0.852, p < 0.001) and creatine phosphokinase at 96 hours (r = 0.687, p < 0.001). Receiver operating characteristic analysis showed excellent discrimination for moderate poisoning and good discrimination for intermediate syndrome. Conclusions Serial serum creatine phosphokinase and lactate dehydrogenase levels were significantly associated with poisoning severity and intermediate syndrome in mild-to-moderate organophosphorus compound poisoning. These inexpensive and widely available biomarkers may be useful adjuncts to clinical assessment, although they should not replace careful monitoring and validated severity assessment. Mortality-related findings require cautious interpretation because only three deaths occurred.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.